Omeros Corporation (OMER)

03:33 AM

Omeros gets FDA acceptance for narsoplimab BLA resubmission - Seeking Alpha

03:33 AM

09:49 AM

FDA Reviews Omeros' (OMER) Resubmission for Narsoplimab Approval | OMER Stock News - GuruFocus

09:49 AM

09:40 AM

FDA reviews Omeros drug for stem cell transplant complication By Investing.com - Investing.com India

09:40 AM

09:16 AM

FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date - Yahoo Finance

09:16 AM

04:10 AM

Barclays PLC Grows Holdings in Omeros Co. (NASDAQ:OMER) - Defense World

04:10 AM

May 05, 2025

Invesco Ltd. Reduces Position in Omeros Co. (NASDAQ:OMER) - Defense World

May 05, 2025

May 03, 2025

JPMorgan Chase & Co. Has $317,000 Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World

May 03, 2025

May 02, 2025

Ratio Revelations: Omeros Corporation (OMER)’s Financial Metrics in the Spotlight - DWinneX

May 02, 2025

May 02, 2025

Omeros Corporation Inc. (OMER) Price Performance: A Fundamental Analysis Perspective - investchronicle.com

May 02, 2025

May 02, 2025

How should investors view Omeros Corporation (OMER)? - uspostnews.com

May 02, 2025

Apr 28, 2025

Omeros Corporation’s Market Journey: Closing Weak at 7.91, Down -3.77 - DWinneX

Apr 28, 2025

Apr 28, 2025

Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Apr 28, 2025

Apr 27, 2025

Omeros Co. (NASDAQ:OMER) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Apr 27, 2025

Apr 27, 2025

Atypical Hemolytic Uremic Syndrome Market Expected Rise, 2034 | Alexion Pharmaceuticals, Omeros Corporation, Novartis Pharmaceuticals, Hoffmann-La Roche, Chugai Pharmaceutical, Expected Drive Market - Barchart.com

Apr 27, 2025

Apr 24, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 24, 2025

Apr 24, 2025

Omeros Corporation (OMER) Stock: A Year of Decreases and Increases - investchronicle.com

Apr 24, 2025

Apr 24, 2025

Market Recap: Omeros Corporation (OMER)’s Negative Momentum, Closing at 6.97 - DWinneX

Apr 24, 2025

Apr 24, 2025

Omeros Co. (NASDAQ:OMER) Shares Acquired by Cerity Partners LLC - Defense World

Apr 24, 2025

Apr 23, 2025

Is it possible to buy Omeros Corporation(OMER) shares at a good price now? - uspostnews.com

Apr 23, 2025

Apr 21, 2025

Omeros Co. (NASDAQ:OMER) Position Increased by Alliancebernstein L.P. - Defense World

Apr 21, 2025

Apr 20, 2025

Franklin Resources Inc. Makes New Investment in Omeros Co. (NASDAQ:OMER) - Defense World

Apr 20, 2025

Apr 15, 2025

Omeros Co. (NASDAQ:OMER) Shares Sold by ExodusPoint Capital Management LP - The AM Reporter

Apr 15, 2025

Apr 15, 2025

Vanguard Group Inc. Reduces Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World

Apr 15, 2025

Apr 13, 2025

Raymond James Financial Inc. Invests $124,000 in Omeros Co. (NASDAQ:OMER) - Defense World

Apr 13, 2025

Apr 13, 2025

D. Boral Capital Reiterates Buy Rating for Omeros (NASDAQ:OMER) - Defense World

Apr 13, 2025

Apr 12, 2025

Corebridge Financial Inc. Sells 2,100 Shares of Omeros Co. (NASDAQ:OMER) - Defense World

Apr 12, 2025

Apr 11, 2025

Omeros' New Leukemia Drug Team Ignites Hope For Cancer FightOmeros (NASDAQ:OMER) - Benzinga

Apr 11, 2025

Apr 11, 2025

Omeros Announces the Omeros Oncology Clinical Steering Committee - GuruFocus

Apr 11, 2025

Apr 10, 2025

Omeros forms steering committee for leukemia treatment By Investing.com - Investing.com South Africa

Apr 10, 2025

Apr 10, 2025

Omeros announces oncology clinical steering committee to help guide proprietary Oncotox-AML clinical program - marketscreener.com

Apr 10, 2025

Apr 10, 2025

Omeros forms steering committee for leukemia treatment - Investing.com

Apr 10, 2025

Apr 10, 2025

Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros’ Proprietary OncotoX-AML Clinical Program - The Joplin Globe

Apr 10, 2025

Apr 09, 2025

Omeros (NASDAQ:OMER) Downgraded by StockNews.com to Sell - Defense World

Apr 09, 2025

Apr 08, 2025

Omeros Corporation To Introduce Its Proprietary T-CAT™ Program for the Treatment of Multidrug-Resistant Pathogens in Plenary Session at Upcoming European Congress on Infectious Diseases - Yahoo

Apr 08, 2025

Apr 07, 2025

It makes sense and dollars to buy Omeros Corporation (OMER) stock - Sete News

Apr 07, 2025

Apr 06, 2025

(OMER) Technical Data - news.stocktradersdaily.com

Apr 06, 2025

Apr 05, 2025

FY2025 EPS Estimates for Omeros Reduced by Cantor Fitzgerald - Defense World

Apr 05, 2025

Apr 03, 2025

Omeros (NASDAQ:OMER) Upgraded to Hold at StockNews.com - The AM Reporter

Apr 03, 2025

Apr 02, 2025

Omeros (NASDAQ:OMER) Earns "Buy" Rating from D. Boral Capital - MarketBeat

Apr 02, 2025

Apr 02, 2025

Omeros Co. (NASDAQ:OMER) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Apr 02, 2025

Apr 02, 2025

4,671 Shares in Omeros Co. (NASDAQ:OMER) Acquired by Quantbot Technologies LP - Defense World

Apr 02, 2025

Apr 02, 2025

Omeros (NASDAQ:OMER) Receives “Hold” Rating from Needham & Company LLC - Defense World

Apr 02, 2025

Apr 02, 2025

Omeros (NASDAQ:OMER) Receives “Buy” Rating from D. Boral Capital - Defense World

Apr 02, 2025

Apr 01, 2025

Omeros Corporation’s Earnings Call Highlights Progress and Challenges - TipRanks

Apr 01, 2025

Apr 01, 2025

Omeros Corporation (NASDAQ:OMER) Q4 2024 Earnings Call Transcript - Insider Monkey

Apr 01, 2025

Apr 01, 2025

Omeros (OMER) Exceeds Q4 EPS Expectations, Reports Cash Decline - GuruFocus

Apr 01, 2025

Apr 01, 2025

Omeros: Q4 Earnings Snapshot - CT Insider

Apr 01, 2025

Apr 01, 2025

Omeros Corp (OMER) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with ... - Yahoo

Apr 01, 2025